Answers are grounded in this paper and cite their sources.
We present a case of Dravet Syndrome (DS) with drug-resistant multifocal epilepsy who we successfully treated using FDA-approved sensing-enabled Percept DBS. Our therapeutic approach involved precise targeting of multiple thalami (centromedian and pulvinar) for DBS to engage and modulate putative epileptogenic circuits.
No takes yet. Share an insight, caveat, or question.
Nayak et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: